Cell & Gene Exchange, May 2017: BrainStorm Cell Therapeutics

June 16, 2017
BrainStorm Cell Therapeutics (NASDAQ:BCLI) is a biotechnology company developing innovative, autologous stem cell therapies for highly debilitating neurodegenerative diseases such as Amyotrophic Lateral Sclerosis (ALS, also known as Lou Gehrig’s disease), Multiple Sclerosis (MS) and Parkinson’s Disease (PD). Speaker: Chaim Lebovits – President and CEO
Previous Video
Cell & Gene Exchange, May 2017: Biostage, Inc.
Cell & Gene Exchange, May 2017: Biostage, Inc.

Biostage is a biotechnology company developing bioengineered organ implants based on the Company's Cellfram...

Next Video
Cell & Gene Exchange, May 2017: Research Cancer Institute of America/Pacific Medical Center of Hope
Cell & Gene Exchange, May 2017: Research Cancer Institute of America/Pacific Medical Center of Hope

Research Cancer Institute of America (RCIA) has established a novel concept and team of scientific experts ...